Newsroom
Articles > Biotechnology and Gene Therapy: Top gainers CLLS, WAT, ALNY, CRL, EDIT
CLLS is trading UP for the last 2 days, and it at trading at $3.01 with volume of 8,947 and a one day change of $0.07 (2.38%). Cellectis S.A. has a 52-week low of 1.42 and a 52-week high of $5.48. The business's 50-day moving average price is $3.53 and its 200 day moving average price is $3.82. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of 3.11.
For more information on CLLS:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
WAT is trading UP for the last 1 days, and it at trading at $375.86 with volume of 1,120,625 and a one day change of $6.99 (1.89%). Waters Corporation has a 52-week low of 275.05 and a 52-week high of $414.15. The business's 50-day moving average price is $346.03 and its 200 day moving average price is $346.84. The firm has a market cap of $22 million, a P/E ratio of 38.99, and a beta of 1.18.
For more information on WAT:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
ALNY is trading UP for the last 2 days, and it at trading at $298.64 with volume of 728,490 and a one day change of $5.12 (1.74%). Alnylam Pharmaceuticals, Inc. has a 52-week low of 273.11 and a 52-week high of $495.55. The business's 50-day moving average price is $296.10 and its 200 day moving average price is $369.33. The firm has a market cap of $59 million, a P/E ratio of 0.00, and a beta of 0.30.
For more information on ALNY:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
CRL is trading UP for the last 6 days, and it at trading at $227.07 with volume of 602,297 and a one day change of $1.50 (0.66%). Charles River Laboratories International, Inc. has a 52-week low of 144.26 and a 52-week high of $228.88. The business's 50-day moving average price is $177.72 and its 200 day moving average price is $179.33. The firm has a market cap of $8 million, a P/E ratio of 26.81, and a beta of 1.64.
For more information on CRL:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
EDIT is trading UP for the last 3 days, and it at trading at $3.22 with volume of 1,228,032 and a one day change of $0.02 (0.47%). Editas Medicine, Inc. has a 52-week low of 1.66 and a 52-week high of $4.54. The business's 50-day moving average price is $2.91 and its 200 day moving average price is $2.67. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of 2.42.
For more information on EDIT:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
Biotechnology and Gene Therapy: Top gainers CLLS, WAT, ALNY, CRL, EDIT
By KlickAnalytics Data Insights | June 30, 2026 04:40PM ET
Following are the Top 5 companies based on their one-day percentage change within the 'Biotechnology and Gene Therapy' theme.
Cellectis S.A. (CLLS)
CLLS is trading UP for the last 2 days, and it at trading at $3.01 with volume of 8,947 and a one day change of $0.07 (2.38%). Cellectis S.A. has a 52-week low of 1.42 and a 52-week high of $5.48. The business's 50-day moving average price is $3.53 and its 200 day moving average price is $3.82. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of 3.11.
For more information on CLLS:
Waters Corporation (WAT)
WAT is trading UP for the last 1 days, and it at trading at $375.86 with volume of 1,120,625 and a one day change of $6.99 (1.89%). Waters Corporation has a 52-week low of 275.05 and a 52-week high of $414.15. The business's 50-day moving average price is $346.03 and its 200 day moving average price is $346.84. The firm has a market cap of $22 million, a P/E ratio of 38.99, and a beta of 1.18.
For more information on WAT:
Alnylam Pharmaceuticals, Inc. (ALNY)
ALNY is trading UP for the last 2 days, and it at trading at $298.64 with volume of 728,490 and a one day change of $5.12 (1.74%). Alnylam Pharmaceuticals, Inc. has a 52-week low of 273.11 and a 52-week high of $495.55. The business's 50-day moving average price is $296.10 and its 200 day moving average price is $369.33. The firm has a market cap of $59 million, a P/E ratio of 0.00, and a beta of 0.30.
For more information on ALNY:
Charles River Laboratories International, Inc. (CRL)
CRL is trading UP for the last 6 days, and it at trading at $227.07 with volume of 602,297 and a one day change of $1.50 (0.66%). Charles River Laboratories International, Inc. has a 52-week low of 144.26 and a 52-week high of $228.88. The business's 50-day moving average price is $177.72 and its 200 day moving average price is $179.33. The firm has a market cap of $8 million, a P/E ratio of 26.81, and a beta of 1.64.
For more information on CRL:
Editas Medicine, Inc. (EDIT)
EDIT is trading UP for the last 3 days, and it at trading at $3.22 with volume of 1,228,032 and a one day change of $0.02 (0.47%). Editas Medicine, Inc. has a 52-week low of 1.66 and a 52-week high of $4.54. The business's 50-day moving average price is $2.91 and its 200 day moving average price is $2.67. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of 2.42.
For more information on EDIT:
This article was generated by KlickAnalytics data insight content engine.
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.